ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
145 hedge funds and large institutions have $1.35B invested in Alder Biopharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 64 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
61% less call options, than puts
Call options by funds: $3.82M | Put options by funds: $9.72M
Holders
145
Holding in Top 10
7
Calls
$3.82M
Puts
$9.72M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$22.3M | |
| 3 | +$21M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$19.2M |
| 5 |
SIG
Senator Investment Group
New York
|
+$17.5M |
Top Sellers
| 1 | -$27.6M | |
| 2 | -$19.1M | |
| 3 | -$10.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.91M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$5.6M |